Iclusig 15 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FMDY7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,287
Award facts
- Contract value 100% obligated
- $29,286.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of ICLUSIG 15 mg tablets (30-count units). This delivery order, awarded on November 25, 2025, carries a ceiling value of approximately $29.3K and an ultimate completion date of December 17, 2025. The award includes no set-aside designation, indicating DMS Pharmaceutical Group Inc. competed in unrestricted federal procurement. ICLUSIG is a specialized oncology medication used in the treatment of certain leukemias, reflecting the company's role as a critical supplier of specialty pharmaceutical products to Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group Inc.'s Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025. The underlying IDC carries a substantial ceiling value of $499.999 billion and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The PPV-G GEN V program authorizes the Defense Logistics Agency to issue delivery orders for comprehensive pharmaceutical and medical supply needs across military healthcare facilities worldwide, and DMS Pharmaceutical Group's established performance on multiple delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FMDY7?
SPE2DR26FMDY7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FMDY7 worth?
The government has obligated $29,287 on SPE2DR26FMDY7.
Is contract SPE2DR26FMDY7 an order under another contract?
Yes. SPE2DR26FMDY7 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDY7 competed?
The extent of competition for SPE2DR26FMDY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award